-+ 0.00%
-+ 0.00%
-+ 0.00%

Werewolf Therapeutics Q1 EPS $(0.28), Inline

Benzinga·05/07/2026 20:45:58
Listen to the news
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 30 percent increase over losses of $(0.40) per share from the same period last year.